Skip to main content
RLMD logo

RLMD · Relmada Therapeutics, Inc. · Exempt Offerings

Track RLMD — free
$2.89 +0.03 (+1.05%) Play latest call Q3 2026 earnings call transcript
Market Cap
$304.61M
Shares
106.69M
Volume · Nov 19 234.1K Avg daily vol (3M) 1.41M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

No Exempt Offerings

No Form D exempt-offering notices are available for this stock yet.

Key facts CIK 1553643 CUSIP 75955J402 13F (30d) 150 filings 132 filers Visit website Investor relations